Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mengqiu Wei, Fengjin Li, Kai Guo & Tianxiao Yang. (2023) Exploring the Active Compounds of Traditional Mongolian Medicine Baolier Capsule (BLEC) in Patients with Coronary Artery Disease (CAD) Based on Network Pharmacology Analysis, Molecular Docking and Experimental Validation. Drug Design, Development and Therapy 17, pages 459-476.
Read now
Read now
Taoli Sun, Wenjuan Quan, Sha Peng, Dongmei Yang, Jiaqin Liu, Chaoping He, Yu Chen, Bo Hu & Qinhui Tuo. (2022) Network Pharmacology-Based Strategy Combined with Molecular Docking and in vitro Validation Study to Explore the Underlying Mechanism of Huo Luo Xiao Ling Dan in Treating Atherosclerosis. Drug Design, Development and Therapy 16, pages 1621-1645.
Read now
Read now
Zhixin Zhang, Jiahui Wang, Yan Lin, Juan Chen, Jian Liu & Xian Zhang. (2022) Nutritional activities of luteolin in obesity and associated metabolic diseases: an eye on adipose tissues. Critical Reviews in Food Science and Nutrition 0:0, pages 1-15.
Read now
Read now
Feng Zhang, Peng Liu, Zhaopeng He, like Zhang, Xinqi He, Feng Liu & Jinsheng Qi. (2022) Crocin ameliorates atherosclerosis by promoting the reverse cholesterol transport and inhibiting the foam cell formation via regulating PPARγ/LXR-α. Cell Cycle 21:2, pages 202-218.
Read now
Read now
Articles from other publishers (24)
Zhongbo Xu, Manyang ShenLin Li. (2023) Exploring the active components and mechanism of modified bazhen decoction in treatment of chronic cerebral circulation insufficiency based on network pharmacology and molecular docking. Medicine 102:29, pages e34341.
Crossref
Crossref
Yuting Chen, Yuanyuan Gan, Jingxuan Yu, Xiao Ye & Wei Yu. (2023) Key ingredients in Verbena officinalis and determination of their anti-atherosclerotic effect using a computer-aided drug design approach. Frontiers in Plant Science 14.
Crossref
Crossref
Lei Huang, Mi-Yeon Kim & Jae Youl Cho. (2023) Immunopharmacological Activities of Luteolin in Chronic Diseases. International Journal of Molecular Sciences 24:3, pages 2136.
Crossref
Crossref
Wenbing Zhi, Yang Liu, Xiumei Wang & Hong Zhang. (2023) Recent advances of traditional Chinese medicine for the prevention and treatment of atherosclerosis. Journal of Ethnopharmacology 301, pages 115749.
Crossref
Crossref
Huan Li, Lei Gao, Huili Shao, Bingqian Li, Chao Zhang, Huagang Sheng & Liqiao Zhu. (2022) Elucidation of active ingredients and mechanism of action of hawthorn in the prevention and treatment of atherosclerosis. Journal of Food Biochemistry 46:12.
Crossref
Crossref
Peng Zhou, Xiao‐Ni Zhao, Yao‐Yao Ma, Tong‐Juan Tang, Shu‐Shu Wang, Liang Wang & Jin‐Ling Huang. (2022)
Virtual screening analysis of natural flavonoids as trimethylamine (
TMA
)‐lyase inhibitors for coronary heart disease
. Journal of Food Biochemistry 46:12.
Crossref
Crossref
Nandakumar Muruganathan, Anand Raj Dhanapal, Venkidasamy Baskar, Pandiyan Muthuramalingam, Dhivya Selvaraj, Husne Aara, Mohamed Zubair Shiek Abdullah & Iyyakkannu Sivanesan. (2022) Recent Updates on Source, Biosynthesis, and Therapeutic Potential of Natural Flavonoid Luteolin: A Review. Metabolites 12:11, pages 1145.
Crossref
Crossref
Xiayinan Song, Xiaoming Wang, Danyang Wang, Zhenzhen Zheng, Jie Li & Yunlun Li. (2022) Natural drugs targeting inflammation pathways can be used to treat atherosclerosis. Frontiers in Pharmacology 13.
Crossref
Crossref
Yiran Zhai, Shiqing Jiang, Binyi Li, Lili Miao, Jie Wang & Shanshan Li. (2022) Potential Mechanisms of Yanghe Decoction in the Treatment of Soft Tissue Sarcoma and Arteriosclerosis Obliterans Based on Network Pharmacology. Chinese medicine and natural products 02:02, pages e77-e88.
Crossref
Crossref
Ruo-Lan Li, Ling-Yu Wang, Shuqin Liu, Hu-Xinyue Duan, Qing Zhang, Ting Zhang, Wei Peng, Yongliang Huang & Chunjie Wu. (2022) Natural Flavonoids Derived From Fruits Are Potential Agents Against Atherosclerosis. Frontiers in Nutrition 9.
Crossref
Crossref
Yi Tao, Fei Zhu, Meiling Pan, Qing Liu & Ping Wang. (2022) Pharmacokinetic, Metabolism, and Metabolomic Strategies Provide Deep Insight Into the Underlying Mechanism of Ginkgo biloba Flavonoids in the Treatment of Cardiovascular Disease. Frontiers in Nutrition 9.
Crossref
Crossref
Rony Abdi Syahputra, Urip Harahap, Aminah Dalimunthe, M. Pandapotan Nasution & Denny Satria. (2022) The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review. Molecules 27:4, pages 1320.
Crossref
Crossref
金涛 何. (2022) Discussion on the Mechanism of Bidens in Treatment of Dyslipidemia Based on Network Pharmacology. Pharmacy Information 11:01, pages 35-45.
Crossref
Crossref
Yasaman Taheri, Javad Sharifi-Rad, Gizem Antika, Yakup Berkay Yılmaz, Tugba Boyunegmez Tumer, Sawsan Abuhamdah, Subhash Chandra, Sarla Saklani, Ceyda Sibel Kılıç, Simona Sestito, Sevgi Durna Daştan, Manoj Kumar, Mohammed M. Alshehri, Simona Rapposelli, Natália Cruz-Martins & William C. Cho. (2021) Paving Luteolin Therapeutic Potentialities and Agro-Food-Pharma Applications: Emphasis on In Vivo Pharmacological Effects and Bioavailability Traits. Oxidative Medicine and Cellular Longevity 2021, pages 1-20.
Crossref
Crossref
Peramaiyan Rajendran, Abdullah M. Alzahrani, Emad A. Ahmed & Vishnu Priya Veeraraghavan. (2021) Kirenol Inhibits B[a]P-Induced Oxidative Stress and Apoptosis in Endothelial Cells via Modulation of the Nrf2 Signaling Pathway. Oxidative Medicine and Cellular Longevity 2021, pages 1-13.
Crossref
Crossref
Wanyun Zuo, Na Liu, Yunhong Zeng, Zhenghui Xiao, Keke Wu, Fan Yang, Biao Li, Qingqing Song, Yunbin Xiao & Qiming Liu. (2021) Luteolin Ameliorates Experimental Pulmonary Arterial Hypertension via Suppressing Hippo-YAP/PI3K/AKT Signaling Pathway. Frontiers in Pharmacology 12.
Crossref
Crossref
Bolin Li, Pengli Du, Yao Du, Danyang Zhao, Yanru Cai, Qian Yang & Zijing Guo. (2021) Luteolin alleviates inflammation and modulates gut microbiota in ulcerative colitis rats. Life Sciences 269, pages 119008.
Crossref
Crossref
Laura Franza, Valentina Carusi, Eleonora Nucera & Franco Pandolfi. (2021) Luteolin, inflammation and cancer: Special emphasis on gut microbiota. BioFactors 47:2, pages 181-189.
Crossref
Crossref
Yuanyuan Zhang, Jia Zhang, Yifan Ren, Teng Li, Jianbin Bi, Zhaoqing Du & Rongqian Wu. (2021) Luteolin Suppresses Sepsis-Induced Cold-Inducible RNA-Binding Protein Production and Lung Injury in Neonatal Mice. Shock 55:2, pages 268-273.
Crossref
Crossref
Alessandro De Stefano, Sabrina Caporali, Nicola Di Daniele, Valentina Rovella, Carmine Cardillo, Francesca Schinzari, Marilena Minieri, Massimo Pieri, Eleonora Candi, Sergio Bernardini, Manfredi Tesauro & Alessandro Terrinoni. (2021) Anti-Inflammatory and Proliferative Properties of Luteolin-7-O-Glucoside. International Journal of Molecular Sciences 22:3, pages 1321.
Crossref
Crossref
霞 王. (2021) Study on Mechanism of Portulacae Herba in Treatment of Atherosclerosis Based on Network Pharmacology. Traditional Chinese Medicine 10:03, pages 427-439.
Crossref
Crossref
Haijun Xiong, Zhaowei Dong, Guanhua Lou, Qingxia Gan, Jin Wang & Qinwan Huang. (2020) Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools. European Journal of Integrative Medicine 40, pages 101241.
Crossref
Crossref
Giovanna Casili, Alessio Ardizzone, Marika Lanza, Enrico Gugliandolo, Marco Portelli, Angela Militi, Salvatore Cuzzocrea, Emanuela Esposito & Irene Paterniti. (2020) Treatment with Luteolin Improves Lipopolysaccharide-Induced Periodontal Diseases in Rats. Biomedicines 8:10, pages 442.
Crossref
Crossref
Laura Toma, Gabriela Sanda, Loredan Niculescu, Mariana Deleanu, Anca Sima & Camelia Stancu. (2020) Phenolic Compounds Exerting Lipid-Regulatory, Anti-Inflammatory and Epigenetic Effects as Complementary Treatments in Cardiovascular Diseases. Biomolecules 10:4, pages 641.
Crossref
Crossref